你可能会喜欢
Canadian Melanoma Conference 2025 👩🏻⚕️🧬🤓 @OncEd thank you ! linkedin.com/posts/erika-ma…
Always sunscreen… always ❄️
Winter sun safety isn't just a summer concern! Protect your skin year-round as UV rays damage skin even on cloudy days and reflect intensely off snow, increasing melanoma risk. The best sunscreen is the one you'll wear consistently! #CureMelanoma #SunSafety
Winter sun safety isn't just a summer concern! Protect your skin year-round as UV rays damage skin even on cloudy days and reflect intensely off snow, increasing melanoma risk. The best sunscreen is the one you'll wear consistently! #CureMelanoma #SunSafety
🤓Just published!!🤓 #oncofertility #pregnancy #Immunotherapy #melanoma #melanomadoctor 👩🏻⚕️ doi.org/10.3390/cancer…
Helpful information 🤓 #medicaloncologist #skindoctor #BCC
WATCH NOW 👀 to help educate yourself about the most common form of skin cancer, Basal Cell Carcinoma (BCC) that makes up about 75% of all non-melanoma skin cancers. BCC tends to grow slowly; however, if left untreated, they can invade other tissues beneath the skin and can…
Happy to be present at @SocietyMelanoma 2024 with our @UHN experience 👩🏻⚕️☝🏼🤓 #melanoma #smr2024 #melanomadoctor #medonc #womeninmedicine #LATINA #100%mexicana
The best neoadjuvant regimen in melanoma is still being investigated. 📍 Neoadjuvant therapy with dual check point inhibition was associated with higher pathologic complete response but also more side effects. #melanomadocotor #skincanceroncologist lnkd.in/e6bAJX_F
A great memory for today. International women’s day 💜🤍
So happy to share my knowledge with our nurse team at PMH 😍 Thanks a lot for the invitation 🩷 #melanomaandskincancerfellow #medicaloncologist #princessmargaret #100porcientomexicana🇲🇽
#Melanoma reminder for today. 👩🏻⚕️ Patients with resectable stage III or IV melanoma may have significantly higher event-free survival with #neoadjuvant #pembrolizumab than among those who received adjuvant alone. #Skincanceroncologist #Melanoma #neoadjuvant #SWOGS1801 #NEJM
Ipililumab with or without Nivolumab in PD1 refractory metastatic Melanoma? #justnew #melanoma #melanomafellow #skincancerdr #onconews #ipililumab #nivo 👩🏻⚕️ linkedin.com/posts/erika-ma…
Adjuvant therapy with nivolumab resulted in an absolute risk reduction of 9% (1-year DFS) and 10% (2-year DFS). Awaiting further data. 🤓 #skincancer #merkelcarcinoma #immunotherapy Reference: Lancet. 2023 Jul11;S0140-6736(23)00769-9. doi: 10.1016/S0140-6736(23)00769-9.
Grateful to work as sub investigator in clinical trials searching for HOPE✨ #melanoma #cancercare #cancerpatients Princess Margaret Cancer Centre linkedin.com/posts/erika-ma…
Every person with #Parkinson should be counseled about the 'double risk' they have of developing a #Melanoma . This is preventable and we are doing a terrible job of 'continuous counseling' and educating in our clinics. We can also teach our persons with Parkinson how to…
Aquellas épocas en las que tuve el gusto de compartir la sala de urgencias con este maestro de la Neurología 🧠@MedinaRiojaMD
Que no se nos olvide a todos que alguna vez fuimos R1. Recuerdos de MI @Erikaadm_c 🏥💊🥼 #Residencia #R1 #MI
United States 趋势
- 1. Syracuse 6,415 posts
- 2. Arch Manning 1,755 posts
- 3. Joe Jackson N/A
- 4. Oregon 25K posts
- 5. Harden 28.4K posts
- 6. Stoops 1,302 posts
- 7. #UFCQatar 71.5K posts
- 8. Jeremiyah Love 2,662 posts
- 9. Lincoln Riley N/A
- 10. Abdullah Mason 1,311 posts
- 11. Arkansas 8,847 posts
- 12. Fran Brown N/A
- 13. Maiava N/A
- 14. Taylen Green N/A
- 15. Arman 21.8K posts
- 16. Mercer 3,143 posts
- 17. Zvada N/A
- 18. #GoIrish 4,420 posts
- 19. Sherrone Moore N/A
- 20. Makai Lemon 1,152 posts
你可能会喜欢
-
INCMNSZ_Uronco
@INCMNSZ_Uronco -
Ana Fernanda RM
@AnaFernandaRM1 -
Mariana Morales
@MoralesGarciaMD -
Brian Ricardo Garibay Vega
@BrianGaribayV -
Basil The Everchosen
@ThorinOSKUTM -
Sore Majzner
@SorafenibMajz -
Pescharizard 🩵
@marianapeschard -
Aldo Lara
@aldolaramd -
Ale Campos
@alecamposch -
Hairless
@DrHairless -
Alexander DeLarge
@alex_olm -
OtraEx-Flaca
@3katia3
Something went wrong.
Something went wrong.